Research Article
BibTex RIS Cite
Year 2023, , 409 - 414, 10.07.2023
https://doi.org/10.31067/acusaglik.1266533

Abstract

References

  • Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin 2021;71(3):209–49.
  • Mokhatri-Hesari P, Montazeri A. Health-related quality of life in breast cancer patients: Review of reviews from 2008 to 2018. Health Qual Life Outcomes 2020;18(1):1–25.
  • Jiang J, Xu J, Cai L, et al. Major depressive symptoms in breast cancer patients with ovarian function suppression: a cross-sectional study comparing ovarian ablation and gonadotropin-releasing hormone agonists. BMC Psychiatry 2021;21(1).
  • NCCN Guidelines for Patients Distress During Cancer Care https://www.nccn.org/patients/guidelines/content/PDF/distress-patient.pdf. Accessed March 11, 2020
  • Carlson LE, Angen M, Cullum J, et al. High levels of untreated distress and fatigue in cancer patients. Br J Cancer 2004 9012 2004;90(12):2297–304.
  • Bultz BD, Groff SL, Fitch M, et al. Implementing screening for distress, the 6th vital sign: a Canadian strategy for changing practice. Psychooncology 2011;20(5):463–9.
  • Linden W, Vodermaier AA, McKenzie R, et al. The Psychosocial Screen for Cancer (PSSCAN): Further validation and normative data. Health Qual Life Outcomes 2009;7(1):1–8.
  • Simons JS, Gaher RM. The Distress Tolerance Scale: Development and Validation of a Self-Report Measure. Motiv Emot 2005 292 2005;29(2):83–102.
  • Leyro TM, Zvolensky MJ, Bernstein A. Distress Tolerance and Psychopathological Symptoms and Disorders: A Review of the Empirical Literature Among Adults. Psychol Bull 2010;136(4):576–600.
  • Brown RJ, Burton AL, Abbott MJ. The relationship between distress tolerance and symptoms of depression: Validation of the Distress Tolerance Scale (DTS) and short-form (DTS-SF). J Clin Psychol 2022;78(12):2609–30.
  • Norr AM, Allan NP, Macatee RJ, et al. The effects of an anxiety sensitivity intervention on anxiety, depression, and worry: Mediation through affect tolerances. Behav Res Ther 2014;59:12–9.
  • Jeffries ER, McLeish AC, Kraemer KM, et al. The Role of Distress Tolerance in the Use of Specific Emotion Regulation Strategies. 2015;40(3):439–51.
  • Lass ANS, Winer ES, Collins AC, et al. The Associations among Distress Tolerance, Unhelpful Coping Behaviors, and Symptoms of Depression: A Network Analysis. Cogn Ther Res 2020 446 2020;44(6):1077–90.
  • Baník G, Gajdošová B. Positive changes following cancer: Posttraumatic growth in the context of other factors in patients with cancer. Support Care Cancer 2014;22(8):2023–9.
  • Bultz BD, Groff SL, Fitch M, et al. Implementing screening for distress, the 6th vital sign: a Canadian strategy for changing practice. Psychooncology 2011;20(5):463–9.
  • Sargin AE, Ozdel K, Utku C, et al. Distress tolerance scale: a study of reliability and validity. J Cogn-Behav Psychother Res 2012; 152-161.
  • Herschbach P, Keller M, Knight L, et al. Psychological problems of cancer patients: a cancer distress screening with a cancer-specific questionnaire. Br J Cancer 2004 913 2004;91(3):504–11.
  • Carlson LE, Zelinski EL, Toivonen KI, et al. Prevalence of psychosocial distress in cancer patients across 55 North American cancer centers. 2018;37(1):5–21.
  • Sighoko D, Hunt BR, Irizarry B, et al. Disparity in breast cancer mortality by age and geography in 10 racially diverse US cities. Cancer Epidemiol 2018;53:178–83.
  • Naik H, Leung B, Laskin J, et al. Emotional distress and psychosocial needs in patients with breast cancer in British Columbia: younger versus older adults. Breast Cancer Res Treat 2020;179(2):471–7.
  • Vella S-LC, Pai NB. A theoretical review of psychological resilience: Defining resilience and resilience research over the decades. Arch Med Heal Sci 2019;7(2):233.
  • Champion VL, Wagner LI, Monahan PO, et al. Comparison of younger and older breast cancer survivors and age-matched controls on specific and overall quality of life domains. Cancer 2014;120(15):2237–46.
  • Goyal RK, Wheeler SB, Kohler RE, et al. Health care utilization from chemotherapy-related adverse events among low-income breast cancer patients: effect of enrollment in a medical home program. N C Med J 2014;75(4):231–8.

Distress Tolerance in Patients with Metastatic and Non-metastatic Breast Cancer: A Single-center Experience

Year 2023, , 409 - 414, 10.07.2023
https://doi.org/10.31067/acusaglik.1266533

Abstract

Background: Psychosocial difficulties occur in patients with breast cancer for many reasons including long-term treatments, organ loss, or deformity. Accordingly, we aimed to compare differences in distress tolerance levels between metastatic and non-metastatic female patients diagnosed with breast cancer and receiving chemotherapy. We also evaluated the possible relationship between distress tolerance levels and with background and clinical characteristics of the patients.

Methods: 208 eligible female patients with breast cancer who received at least three chemotherapy sessions were included in our study. According to the presence of metastasis, the patients were divided into two groups those receiving palliative (metastatic, n=126) and adjuvant (non-metastatic, n=82) chemotherapy. Besides the study-specific data form, the Distress Tolerance Scale (DTS) was applied to patients to assess distress tolerance levels.

Results: The age of participants was statistically significant between the non-metastatic and metastatic patients(p<0.05). There was no significant statistical difference in DTS scores between non-metastatic and metastatic patients. DTS levels were significantly correlated with the presence of inpatient admission. Multiple linear regression analysis indicated that the absence of inpatient admission was significantly associated with DTS levels in patients with breast cancer(B:-13.792, p<0.01).

Conclusion: Distress tolerance is important in such a long-term illness to cope with the difficulties in the treatment. DTS may not be directly related to the stage of illness. Since inpatient admission reduces distress tolerance, it may be important in the treatment processes of these patients. Preventing possible causes of hospitalization may have positive effects on the capacity of these patients to cope with stress.

References

  • Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin 2021;71(3):209–49.
  • Mokhatri-Hesari P, Montazeri A. Health-related quality of life in breast cancer patients: Review of reviews from 2008 to 2018. Health Qual Life Outcomes 2020;18(1):1–25.
  • Jiang J, Xu J, Cai L, et al. Major depressive symptoms in breast cancer patients with ovarian function suppression: a cross-sectional study comparing ovarian ablation and gonadotropin-releasing hormone agonists. BMC Psychiatry 2021;21(1).
  • NCCN Guidelines for Patients Distress During Cancer Care https://www.nccn.org/patients/guidelines/content/PDF/distress-patient.pdf. Accessed March 11, 2020
  • Carlson LE, Angen M, Cullum J, et al. High levels of untreated distress and fatigue in cancer patients. Br J Cancer 2004 9012 2004;90(12):2297–304.
  • Bultz BD, Groff SL, Fitch M, et al. Implementing screening for distress, the 6th vital sign: a Canadian strategy for changing practice. Psychooncology 2011;20(5):463–9.
  • Linden W, Vodermaier AA, McKenzie R, et al. The Psychosocial Screen for Cancer (PSSCAN): Further validation and normative data. Health Qual Life Outcomes 2009;7(1):1–8.
  • Simons JS, Gaher RM. The Distress Tolerance Scale: Development and Validation of a Self-Report Measure. Motiv Emot 2005 292 2005;29(2):83–102.
  • Leyro TM, Zvolensky MJ, Bernstein A. Distress Tolerance and Psychopathological Symptoms and Disorders: A Review of the Empirical Literature Among Adults. Psychol Bull 2010;136(4):576–600.
  • Brown RJ, Burton AL, Abbott MJ. The relationship between distress tolerance and symptoms of depression: Validation of the Distress Tolerance Scale (DTS) and short-form (DTS-SF). J Clin Psychol 2022;78(12):2609–30.
  • Norr AM, Allan NP, Macatee RJ, et al. The effects of an anxiety sensitivity intervention on anxiety, depression, and worry: Mediation through affect tolerances. Behav Res Ther 2014;59:12–9.
  • Jeffries ER, McLeish AC, Kraemer KM, et al. The Role of Distress Tolerance in the Use of Specific Emotion Regulation Strategies. 2015;40(3):439–51.
  • Lass ANS, Winer ES, Collins AC, et al. The Associations among Distress Tolerance, Unhelpful Coping Behaviors, and Symptoms of Depression: A Network Analysis. Cogn Ther Res 2020 446 2020;44(6):1077–90.
  • Baník G, Gajdošová B. Positive changes following cancer: Posttraumatic growth in the context of other factors in patients with cancer. Support Care Cancer 2014;22(8):2023–9.
  • Bultz BD, Groff SL, Fitch M, et al. Implementing screening for distress, the 6th vital sign: a Canadian strategy for changing practice. Psychooncology 2011;20(5):463–9.
  • Sargin AE, Ozdel K, Utku C, et al. Distress tolerance scale: a study of reliability and validity. J Cogn-Behav Psychother Res 2012; 152-161.
  • Herschbach P, Keller M, Knight L, et al. Psychological problems of cancer patients: a cancer distress screening with a cancer-specific questionnaire. Br J Cancer 2004 913 2004;91(3):504–11.
  • Carlson LE, Zelinski EL, Toivonen KI, et al. Prevalence of psychosocial distress in cancer patients across 55 North American cancer centers. 2018;37(1):5–21.
  • Sighoko D, Hunt BR, Irizarry B, et al. Disparity in breast cancer mortality by age and geography in 10 racially diverse US cities. Cancer Epidemiol 2018;53:178–83.
  • Naik H, Leung B, Laskin J, et al. Emotional distress and psychosocial needs in patients with breast cancer in British Columbia: younger versus older adults. Breast Cancer Res Treat 2020;179(2):471–7.
  • Vella S-LC, Pai NB. A theoretical review of psychological resilience: Defining resilience and resilience research over the decades. Arch Med Heal Sci 2019;7(2):233.
  • Champion VL, Wagner LI, Monahan PO, et al. Comparison of younger and older breast cancer survivors and age-matched controls on specific and overall quality of life domains. Cancer 2014;120(15):2237–46.
  • Goyal RK, Wheeler SB, Kohler RE, et al. Health care utilization from chemotherapy-related adverse events among low-income breast cancer patients: effect of enrollment in a medical home program. N C Med J 2014;75(4):231–8.
There are 23 citations in total.

Details

Primary Language English
Subjects Psychiatry, Oncology and Carcinogenesis
Journal Section Research Article
Authors

Gülçin Şahingöz Erdal 0000-0001-5815-5847

Simge Seren Kırlıoğlu Balcıoğlu 0000-0001-9778-6617

Mustafa Nuray Namlı 0000-0001-9778-4216

Early Pub Date June 23, 2023
Publication Date July 10, 2023
Submission Date March 17, 2023
Published in Issue Year 2023

Cite

EndNote Şahingöz Erdal G, Kırlıoğlu Balcıoğlu SS, Namlı MN (July 1, 2023) Distress Tolerance in Patients with Metastatic and Non-metastatic Breast Cancer: A Single-center Experience. Acıbadem Üniversitesi Sağlık Bilimleri Dergisi 14 3 409–414.